CIK 0001133869
- Non-accelerated filer
- Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 310-358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-21 | Manzo Louis Director | Option exercise | +1,401 | $1.39 | $2K | 62,599 |
| 2023-02-21 | Manzo Louis Director | Returned to the company | −452 | $4.31 | $2K | 62,147 |
| 2023-02-21 | Manzo Louis Director | Option exercise · Stock Option (Right to Buy) | −1,401 | 0 | ||
| 2023-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +37,770 | 37,770 | ||
| 2023-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +7,120 | 7,120 | ||
| 2023-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2022-03-31 | Manzo Louis Director | Option exercise | +27,904 | $1.39 | $39K | 27,904 |
| 2022-03-31 | Manzo Louis Director | Shares withheld for taxes | −11,309 | $3.43 | $39K | 16,595 |
| 2022-03-31 | Manzo Louis Director | Option exercise · Stock Option (Right to Buy) | −15,455 | 0 | ||
| 2022-03-31 | Manzo Louis Director | Option exercise · Stock Option (Right to Buy) | −12,449 | 0 | ||
| 2022-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +83,590 | 83,590 | ||
| 2021-01-04 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +72,066 | 72,066 | ||
| 2020-09-24 | Manzo Louis Director | Option exercise | +8,299 | $3.70 | $31K | 44,603 |
| 2020-09-24 | Manzo Louis Director | Option exercise · Stock Option (Right to Buy) | −8,299 | 0 | ||
| 2020-06-05 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +83,000 | 83,000 | ||
| 2020-02-12 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +4,500 | 4,500 | ||
| 2020-02-12 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +2,550 | 2,550 | ||
| 2020-02-12 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +2,356 | 2,356 | ||
| 2020-02-12 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2020-02-12 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +1,500 | 1,500 |
Page 1 of 3 · 42 trades